In a study from Portugal with eight patients with TNF-alpha inhibitors induced liver injury (infliximab = 7, adalimumab = 1), all were treated with corticosteroids and had normalization of liver tests and those who discontinued immunosuppression did not have a relapse of AIH (Rodrigues et al., 2015). The gene discussed is TNF; the disease is autoimmune hepatitis.